AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. RPRX
  4. [8-K] Royalty Pharma plc Reports Material Event

[8-K] Royalty Pharma plc Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock RPRX logo
Royalty Pharma Plc

NASDAQ:RPRX

RPRX Rankings

#804 Ranked by Market Cap
#1270 Ranked by Dividends

RPRX Latest News

Jul 18, 2025
Royalty Pharma Declares Third Quarter 2025 Dividend
Jul 17, 2025
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors
Jul 16, 2025
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025
Jun 4, 2025
Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
May 16, 2025
Royalty Pharma Completes the Acquisition of Its External Manager

RPRX Latest SEC Filings

Jul 25, 2025
[Form 3] Royalty Pharma plc Initial Statement of Beneficial Ownership
Jul 25, 2025
[Form 3] Royalty Pharma plc Initial Statement of Beneficial Ownership
Jun 30, 2025
[Form 4] Royalty Pharma plc Insider Trading Activity
Jun 30, 2025
[Form 4] Royalty Pharma plc Insider Trading Activity

RPRX Stock Data

15.17B
382.26M
9.83%
76.7%
3.17%
Biotechnology
Pharmaceutical Preparations
United States
NEW YORK